Merck's Ebola Vaccine Is 'Highly Effective'

Merck & Co.’s vaccine for Ebola is “highly effective,” according to an interim analysis from a panel of experts who recommended that a late-stage trial should continue. Bloomberg's Drew Armstrong reports on "Market Makers." (Source: Bloomberg)